PBMs had hidden role in opioid crisis, NYT investigation finds
Documents show pharmacy benefit managers helped drugmakers like Purdue Pharma dole out opioids in exchange for payouts.
Documents show pharmacy benefit managers helped drugmakers like Purdue Pharma dole out opioids in exchange for payouts.
The chain is reportedly in talks for a deal with private equity firm Sycamore Partners.
Pharmacies are shuttering, and patients of color are hit harder from the closures, according to new research.
While both drugs are GLP-1s, they have different active ingredients.
On November 25, Cassava Sciences ended a Phase 3 trial of its controversial Alzheimer’s drug, simufilam, following years of scrutiny.
Genomic testing could diagnose rare diseases within weeks, but misconceptions are slowing progress, GeneDx CEO says.
Healthcare Brew covers pharmaceutical developments, health startups, the latest tech, and how it impacts hospitals and providers to keep administrators and providers informed.